Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Oncology
Lung Cancer
,
Infectious Diseases
,
Oncology
Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care
Walter Alexander
Walter Alexander
Read More
Lung Cancer
,
Oncology
EGFR Most Common Mutation in Women with Lung Cancer and No Smoking History
Walter Alexander
Walter Alexander
Read More
Breast Cancer
,
Oncology
Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases
Phoebe Starr
Read More
Breast Cancer
,
Oncology
First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer
Phoebe Starr
Read More
FDA Approvals
,
Multiple Myeloma
,
Oncology
FDA Approved Pepaxto for Relapsed or Refractory Multiple Myeloma
Read More
FDA Approvals
,
Multiple Myeloma
,
Oncology
FDA Approved Abecma, First CAR T-Cell Therapy for Multiple Myeloma
Read More
In the Literature
,
Oncology
Pembrolizumab Shows Long-Term Benefits in Metastatic Colorectal Cancer and MSI-H or dMMR
Read More
In the Literature
,
Gastroenterology
,
Oncology
Sitagliptin, DPP-4 Inhibitor, Reduces the Incidence of Acute GVHD After Stem-Cell Transplant
Read More
Cholangiocarcinoma
,
Oncology
Emerging Molecular Targets in Cholangiocarcinoma: IDH1, HER2, BRAF, and Beyond
Read More
Cholangiocarcinoma
,
Oncology
Targeted Therapies in Cholangiocarcinoma
Read More
1
2
3
4
5
6
Page 3 of 27
Results 21 - 30 of 262